These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37683590)
1. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism. Sun X; Zhang Y; Cheng G; Zhu T; Zhang Z; Xiong L; Hu H; Liu H Biomed Pharmacother; 2023 Nov; 167():115430. PubMed ID: 37683590 [TBL] [Abstract][Full Text] [Related]
2. Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota. Li X; Xu S; Zhang Y; Li K; Gao XJ; Guo MY Microbiol Spectr; 2022 Dec; 10(6):e0320722. PubMed ID: 36287004 [TBL] [Abstract][Full Text] [Related]
3. Combination of Coptis chinensis polysaccharides and berberine ameliorates ulcerative colitis by regulating gut microbiota and activating AhR/IL-22 pathway. Wang X; Liang F; Dai Z; Feng X; Qiu F J Ethnopharmacol; 2024 Jan; 318(Pt B):117050. PubMed ID: 37595814 [TBL] [Abstract][Full Text] [Related]
4. Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon. Cui H; Cai Y; Wang L; Jia B; Li J; Zhao S; Chu X; Lin J; Zhang X; Bian Y; Zhuang P Front Pharmacol; 2018; 9():571. PubMed ID: 29904348 [TBL] [Abstract][Full Text] [Related]
5. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228 [TBL] [Abstract][Full Text] [Related]
6. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway. Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867 [TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway. Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677 [TBL] [Abstract][Full Text] [Related]
8. Integration of microbiome, metabolomics and transcriptome for in-depth understanding of berberine attenuates AOM/DSS-induced colitis-associated colorectal cancer. Wang M; Ma Y; Yu G; Zeng B; Yang W; Huang C; Dong Y; Tang B; Wu Z Biomed Pharmacother; 2024 Oct; 179():117292. PubMed ID: 39151314 [TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism. Dong S; Zhu M; Wang K; Zhao X; Hu L; Jing W; Lu H; Wang S Pharmacol Res; 2021 Sep; 171():105767. PubMed ID: 34273490 [TBL] [Abstract][Full Text] [Related]
10. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota. Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224 [TBL] [Abstract][Full Text] [Related]
11. Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5. Hua YL; Jia YQ; Zhang XS; Yuan ZW; Ji P; Hu JJ; Wei YM Biomed Pharmacother; 2021 May; 137():111320. PubMed ID: 33578232 [TBL] [Abstract][Full Text] [Related]
12. Herba Origani alleviated DSS-induced ulcerative colitis in mice through remolding gut microbiota to regulate bile acid and short-chain fatty acid metabolisms. Yu Z; Li D; Sun H Biomed Pharmacother; 2023 May; 161():114409. PubMed ID: 36822021 [TBL] [Abstract][Full Text] [Related]
13. Intestinal and hepatic benefits of BBR-EVO on DSS-induced experimental colitis in mice. Wang W; Han Y; Yin W; Wang Q; Wu Y; Du M Front Microbiol; 2024; 15():1428327. PubMed ID: 39296302 [TBL] [Abstract][Full Text] [Related]
14. Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function. Hu J; Huang H; Che Y; Ding C; Zhang L; Wang Y; Hao H; Shen H; Cao L J Ethnopharmacol; 2021 Feb; 266():113394. PubMed ID: 32941971 [TBL] [Abstract][Full Text] [Related]
15. Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades. Wang K; Guo J; Chang X; Gui S J Pharm Biomed Anal; 2022 Feb; 209():114529. PubMed ID: 34915325 [TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis. Zheng C; Wang Y; Xu Y; Zhou L; Hassan S; Xu G; Zou X; Zhang M Int Immunopharmacol; 2021 Dec; 101(Pt A):108329. PubMed ID: 34749293 [TBL] [Abstract][Full Text] [Related]
17. Codonopsis pilosula polysaccharide alleviates ulcerative colitis by modulating gut microbiota and SCFA/GPR/NLRP3 pathway. Zhou J; Yang Q; Wei W; Huo J; Wang W J Ethnopharmacol; 2025 Jan; 337(Pt 2):118928. PubMed ID: 39393557 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of berberine hydrochloride and dehydrocostus lactone in the treatment of ulcerative colitis: Take gut microbiota as the target. Xu C; Zhao L; Zhou W; Li Y; Hu H; Wang Z Int Immunopharmacol; 2023 Nov; 124(Pt B):111009. PubMed ID: 37820424 [TBL] [Abstract][Full Text] [Related]
19. Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity. Niu C; Hu XL; Yuan ZW; Xiao Y; Ji P; Wei YM; Hua YL J Ethnopharmacol; 2023 Jan; 300():115741. PubMed ID: 36162543 [TBL] [Abstract][Full Text] [Related]
20. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine. Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]